Page 68 - Read Online
P. 68

Schreiner et al. Plast Aesthet Res 2018;5:32  I  http://dx.doi.org/10.20517/2347-9264.2018.45                                       Page 5 of 6

               lateral pectoralis major muscle has therefore been preferred in our patients. The chest wall reconstruction
               using the pectoral PMF enabling successful long-term infection control within the SCJ has already been de-
               scribed [6,15,16] . In addition to the described technique, other clinically important issues have to be taken into
               consideration. Firstly, the higher perioperative risk associated with the liver impairment has to be expected.
               Therefore, staged procedure adapted to the reduced patient status is recommended. Secondly, a wide involve-
               ment of the neighbouring structures and mediastinum was present in all our cases. Finally, the aggressive
               one stage approach with the SCJ resection and simultaneous muscle transposition is associated with higher
               complication rate and can be replaced by the presented staged strategy.


               In conclusion, the staged NPT based surgical therapy of the acute SCJ infections in patients with hepatic
               impairment is feasible. It helps reduce the high perioperative morbidity, maintaining the principles of wound
               management. The presence of liver dysfunction and consequent coagulopathy is associated with increased
               blood product demand and requires a well-balanced interdisciplinary approach.


               DECLARATIONS
               Authors’ contributions
               Study design: Schreiner W, Horch RE, Sirbu H
               Sequence alignment and manuscript drafting: Schreiner W, Dudek W, Trufa DI
               Statistical analysis: Schreiner W
               Coordination of the study: Horch RE, Sirbu H
               Read and approved the final manuscript: all authors

               Availability of data and materials
               Results are reported in the manuscript, patient´s individual data are not available to the public for the sake of
               data protection laws.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               There are no ethical concerns over the study.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2018.



               REFERENCES
               1.   Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis. Review of 180 cases. Medicine (Baltimore) 2004;83:139-48.
               2.   Bakaeen FG, Huh J, Fagan SP, Bellows CF. Surgical treatment of sternoclavicular joint infections in cirrhotic patients. Am J Surg
                   2008;195:130-3.
               3.   Kamath PS, Wiener RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR. A model to predict
                   survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
               4.   Abu Arab W, Khadragui I, Echavé V, Deshaies A, Sirois C, Sirois M. Surgical management of sternoclavicular joint infection. Eur J
                   Cardiothorac Surg 2011;40:630-5.
               5.   Guerra C, Spillane LL. Sternoclavicular septic arthritis in a patient with end-stage liver disease. Ann Emerg Med 1996;27:264-6.
               6.   Song HK, Guy TS, Kaiser LR, Shrager JB. Current presentation and optimal surgical management of sternoclavicular joint infections.
                   Ann Thorac Surg 2002;73:427-31.
               7.   Puri V, Meyers BF, Kreisel D, Patterson GA, Crabtree TD, Battafarano RJ, Krupnick AS. Sternoclavicular joint resection: a comparison
   63   64   65   66   67   68   69   70   71   72   73